An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, February 20th at 4:30 PM EST for a presentation by Dr. Jorge Mera of Cherokee Nation. Dr. Mera will present on:
“The Cherokee Nation HCV Elimination Program: Lessons Learned and Moving Forward”
About Dr. Mera:
Dr. Jorge Mera is the director of infectious diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. During the last years his efforts have been dedicated to organizing the Cherokee Nation HCV elimination program as well as the HIV/HCV Extended Care Health Outcomes (ECHO) project in the tribe. He is also the Director of the HIV clinic since 2012 and the Director of the only Native American AETC local performance site in Oklahoma since 2013. Dr. Mera completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.
On Tuesday, February 13th, Dr. George Ioannou of the University of Washington presented on: “Antiviral treatment for hepatitis C virus and risk of hepatocellular carcinoma”
About Dr. Ioannou:
Dr. George Ioannou is the Director of Hepatology at the Veterans Affairs Puget Sound Healthcare System and an Associate Professor of Medicine at the University of Washington. He is also the co-Director of the VA Hepatitis C Innovation Team for VA Network 20 (VISN 20).
His research interests include epidemiological and clinical studies of hepatitis C, hepatocellular carcinoma and cirrhosis as well as liver transplant outcomes.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.